BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 14729971)

  • 1. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.
    Cheng JC; Weisenberger DJ; Gonzales FA; Liang G; Xu GL; Hu YG; Marquez VE; Jones PA
    Mol Cell Biol; 2004 Feb; 24(3):1270-8. PubMed ID: 14729971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
    Cheng JC; Matsen CB; Gonzales FA; Ye W; Greer S; Marquez VE; Jones PA; Selker EU
    J Natl Cancer Inst; 2003 Mar; 95(5):399-409. PubMed ID: 12618505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
    Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.
    Champion C; Guianvarc'h D; Sénamaud-Beaufort C; Jurkowska RZ; Jeltsch A; Ponger L; Arimondo PB; Guieysse-Peugeot AL
    PLoS One; 2010 Aug; 5(8):e12388. PubMed ID: 20808780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
    Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP
    Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
    Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
    Billam M; Sobolewski MD; Davidson NE
    Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia.
    Lemaire M; Momparler LF; Bernstein ML; Marquez VE; Momparler RL
    Anticancer Drugs; 2005 Mar; 16(3):301-8. PubMed ID: 15711182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.
    Nakamura K; Aizawa K; Nakabayashi K; Kato N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2013; 8(1):e54036. PubMed ID: 23320119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
    Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
    Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
    Hassler MR; Klisaroska A; Kollmann K; Steiner I; Bilban M; Schiefer AI; Sexl V; Egger G
    Biochimie; 2012 Nov; 94(11):2297-307. PubMed ID: 22687603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential response of cancer cells to zebularine.
    Cheng JC; Yoo CB; Weisenberger DJ; Chuang J; Wozniak C; Liang G; Marquez VE; Greer S; Orntoft TF; Thykjaer T; Jones PA
    Cancer Cell; 2004 Aug; 6(2):151-8. PubMed ID: 15324698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
    Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
    Cui X; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K; Hirano S
    Hum Pathol; 2006 Mar; 37(3):298-311. PubMed ID: 16613325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor.
    Gray SG; Baird AM; O'Kelly F; Nikolaidis G; Almgren M; Meunier A; Dockry E; Hollywood D; Ekström TJ; Perry AS; O'Byrne KJ
    Int J Mol Med; 2012 Dec; 30(6):1505-11. PubMed ID: 23007409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI.
    Ye K; Wang S; Wang J; Han H; Ma B; Yang Y
    Cancer Sci; 2016 Dec; 107(12):1851-1857. PubMed ID: 27685841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.
    Gnyszka A; Jastrzebski Z; Flis S
    Anticancer Res; 2013 Aug; 33(8):2989-96. PubMed ID: 23898051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells.
    Han H; Yang X; Pandiyan K; Liang G
    PLoS One; 2013; 8(9):e75136. PubMed ID: 24040395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
    Datta J; Ghoshal K; Denny WA; Gamage SA; Brooke DG; Phiasivongsa P; Redkar S; Jacob ST
    Cancer Res; 2009 May; 69(10):4277-85. PubMed ID: 19417133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation.
    Hodge DR; Peng B; Cherry JC; Hurt EM; Fox SD; Kelley JA; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jun; 65(11):4673-82. PubMed ID: 15930285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.